The most notable overall observation in this investigation is the lack of evidence to support a significant association between ERBB2 genomic sequence variants (SVs) and HBC initiation, despite the wealth of information supporting its role in breast cancer progression [16], [31], [32]. The gene discussed is ERBB2; the disease is breast carcinoma.